FINASTERIDE by Teva is 5α-reductase, an intracellular enzyme that converts the androgen testosterone into dht. Approved for male pattern hair loss (androgenetic alopecia) in men only ( ). First approved in 2013.
Drug data last refreshed 23h ago
5α-reductase, an intracellular enzyme that converts the androgen testosterone into DHT. Two distinct isozymes are found in mice, rats, monkeys, and humans: Type I and II. Each of these isozymes is differentially expressed in tissues and developmental stages. In humans, Type I 5 α-reductase is…
Worked on FINASTERIDE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)
Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy
A Trial of PROSCAR (Finasteride) Versus Placebo in Men With an Initial Negative Prostate Biopsy